Search results
Moderna and Novavax Hope for Early Launch of This Year’s Covid-19 Shots, Despite FDA Delay
Barrons.com· 1 day agoModerna CEO Stéphane Bancel recently told Barron’s that launching the shots in August instead of...
European Patent Office Sides with Moderna In COVID-19 Vaccine Patent Dispute With Pfizer/BioNTech
Benzinga· 4 days agoModerna Inc MRNA has reportedly achieved a significant victory at the European Patent Office (EPO)...
Moderna and Novavax Hope for Early Launch of This Year’s Covid-19 Shots
Barrons.com· 1 day agoAfter disappointing sales for their Covid vaccines last year, Moderna, Novavax, and Pfizer are...
Pfizer wins $107.5 million from AstraZeneca in US cancer drug patent trial
AOL· 4 days agoAstraZeneca owes Pfizer $107.5 million in damages, a Delaware federal jury said on Friday after finding that AstraZeneca's blockbuster lung cancer drug Tagrisso violated its ...
Spotlight on Pfizer: Analyzing the Surge in Options Activity - Pfizer (NYSE:PFE)
Benzinga· 5 days agoLoading... Loading... Deep-pocketed investors have adopted a bullish approach towards Pfizer PFE , and it's something market players shouldn't ignore. Our tracking of public ...
High salaries, poor performance: These were the most overpaid CEOs last year
Fast Company Magazine· 9 hours agoWhen it comes to CEO salaries, no one topped Broadcom’s Hock Tan last year. Among the worst...
Pfizer Inc. (PFE) Is a Trending Stock: Facts to Know Before Betting on It
Zacks· 5 days agoFree Report) has recently been on Zacks.com's list of the most searched stocks. The Zacks Large Cap Pharmaceuticals industry, to which Pfizer belongs, has gained 6.3% over ...
Woburn startup Gradiant has new tech to zap ‘forever chemicals’ - The Boston Globe
The Boston Globe· 12 hours agoAmid a growing awareness that drinking water is contaminated with harmful “forever chemicals,” one...
WSJ Future of Everything Festival Features Interviews With Ray Dalio, Lina Khan, Awkwafina
The Wall Street Journal· 12 hours agoThe Wall Street Journal’s Future of Everything Festival kicked off Tuesday, with top innovators,...
Pfizer offers up to $250 million to settle Zantac cancer lawsuits, FT reports
AOL· 6 days agoThe drugmaker was set to pay between $200 million and $250 million in the settlement, the newspaper reported, citing two people briefed on the deal. The settlement was disclosed in a court filing ...